Results 91 to 100 of about 4,215 (171)

Novel insights into Alzheimer's disease through the study of individuals with Down syndrome. [PDF]

Alzheimers Dement
Head E, Cohen A, Fortea J, McGlinchey E.
europepmc   +1 more source

Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. <i>Pharmaceutics</i> 2025, <i>17</i>, 128. [PDF]

Pharmaceutics
Ortiz-Islas E, Montes P, Rodríguez-Pérez CE, Ruiz-Sánchez E, Sánchez-Barbosa T, Pichardo-Rojas D, Zavala-Tecuapetla C, Carvajal-Aguilera K, Campos-Peña V.   +8 more
europepmc   +1 more source

Cannabinoid CB₁ receptors drive oligodendrocyte maturation during myelin regeneration. [PDF]

Cell Commun Signal
Ezquerro-Herce S, Sánchez-de la Torre A, Monory K, Lutz B, Guzmán M, Aguado T, Palazuelos J.   +6 more
europepmc   +1 more source

Sleep-related changes in astrocytic biomarkers are modulated by <i>APOE</i> ε4 genotype in cognitively unimpaired adults. [PDF]

Brain Commun
Zhu N, Altuna M, Arranz J, Rodriguez-Baz Í, Sanchez-Saudinós MB, Videla L, Valldeneu S, Carrera-Vega M, Romero S, Fortea J, Lleó A, Giménez S, Alcolea D.   +12 more
europepmc   +1 more source

Cortical asymmetry in autosomal dominant Alzheimer's disease progression. [PDF]

Brain Commun
Pérez-Millan A, Falgàs N, Bosch B, Borrego-Écija S, Antonell A, Fernández-Villullas G, Esteller-Gauxax D, Tort-Merino A, Bargalló N, Balasa M, Lladó A, Aguillon D, Chrem P, Day GS, Devenney E, Huey ED, Ikeuchi T, Jucker M, Kasuga K, Vöglein J, Roh JH, Vitali P, Sosa Ortiz AL, Llibre-Guerra JJ, Gordon BA, McDade E, Bateman RJ, Sánchez-Valle R, Dominantly Inherited Alzheimer Network (DIAN) .   +28 more
europepmc   +1 more source

Lifestyle intervention and cognitive outcomes in Down syndrome: a horizon 21 European Down syndrome consortium scoping review. [PDF]

J Neurodev Disord
McGlinchey E, Pape S, Zaman SH, Eustace-Cook J, Stockbauer A, Baldimtsi E, Langballe EM, Larsen FK, Sandkühler K, Ivain P, Rebillat AS, Ecrement P, McCarron M, Benejam B, Khoo WM, Fortea J, Levin J, Öhman F, Granholm-Bentley AC, Strydom A, Nübling G.   +20 more
europepmc   +1 more source

Alteraciones epigenéticas en enfermedades neurodegenerativas

En las últimas dos décadas, el avance constante de tecnologías experimentales y computacionales, así como de tecnologías de alto rendimiento, ha proporcionado conocimientos críticos sobre el funcionamiento del cerebro en estados de salud y enfermedad.
openaire   +1 more source

Diabetes tipo 2 y enfermedades neurodegenerativas

, 2017
En la última década, varios estudios preclínicos y clínicos han confirmado la existencia de una clara relación entre la Diabetes Mellitus tipo 2 (DMT2) y la enfermedad de Alzheimer (EA), al incrementarse el riesgo de padecer EA en pacientes diabéticos.
openaire   +1 more source

Editorial: Unraveling the mysteries of aging and the brain: advancements in understanding neurodegenerative diseases and dementia. [PDF]

Front Genet
Campos-Peña V.
europepmc   +1 more source

Special Issue "Role of NRF2 Pathway in Chronic Diseases". [PDF]

Int J Mol Sci
García-Yagüe ÁJ.
europepmc   +1 more source